You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

amegakaryocytic thrombocytopenia

Showing 1 - 25 of 646
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human

Completed
  • Mucopolysaccharidosis I
  • +15 more
  • Human Placental Derived Stem Cell
  • Denver, Colorado
  • +2 more
Oct 24, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United

Recruiting
  • Bone Marrow Failure Syndrome
  • +6 more
  • Los Angeles, California
  • +23 more
Aug 15, 2022

Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection

Active, not recruiting
  • Bone Marrow Failure Syndrome
  • +15 more
  • CD34 Stem Cell Selection Therapy
  • New York, New York
    Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
Jun 17, 2020

Cancer in Inherited Bone Marrow Failure Syndromes

Recruiting
  • Diamond Blackfan Anemia
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Jan 24, 2023

    Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

    Recruiting
    • Primary Immunodeficiency (PID)
    • +4 more
    • data collection
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    Feb 9, 2022

    Eltrombopag Trial in Assiut (Eltrombopag)

    Completed
    • Eltrombopag
    • Assiut, Egypt
      Facility of medicine
    Jan 13, 2022

    Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)

    Completed
    • Chemotherapy-induced Thrombocytopenia
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    May 5, 2023

    Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • eltrombopag and romiplastim
    • (no location specified)
    Nov 16, 2023

    Thrombocytopenia Trial (Hetrombopag)

    Not yet recruiting
    • Thrombocytopenia
    • (no location specified)
    Sep 7, 2023

    Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911, Placebo)

    Recruiting
    • Chemotherapy-induced Thrombocytopenia
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Sep 21, 2022

    Outcome of Thrombocytopenia in ICU Patients

    Not yet recruiting
    • Thrombocytopenia
      • (no location specified)
      Jul 15, 2023

      Thrombocytopenia Purpura, Chronic HBV Infection Trial in Tianjin (Eltrombopag)

      Completed
      • Thrombocytopenia Purpura
      • Chronic HBV Infection
      • Tianjin, Tianjin, China
        Ethics Committee of Blood disease hospital, Chinese Academy of M
      Jan 24, 2023

      Study of Severe Fever With Thrombocytopenia Syndrome

      Recruiting
      • Severe Fever With Thrombocytopenia Syndrome
        • Guangshui, Hubei, China
        • +7 more
        Aug 21, 2023

        Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

        Recruiting
        • Myelofibrosis
        • Saint Louis, Missouri
          Washington University School of Medicine
        Oct 26, 2022

        Ketogenic Diet Trial (Strict ketogenic diet group, Cyclic ketogenic diet group, Autonomous ketogenesis group)

        Not yet recruiting
        • Ketogenic Diet
        • Strict ketogenic diet group
        • +2 more
        • (no location specified)
        Oct 26, 2023

        Systemic Lupus Erythematosus Trial (Telitacicept, conventional therapy, Placebo)

        Not yet recruiting
        • Systemic Lupus Erythematosus
        • (no location specified)
        Jun 26, 2023

        Connective Tissue Diseases, Thrombocytopenia Trial in China (Telitacicept, Placebo)

        Not yet recruiting
        • Connective Tissue Diseases
        • Thrombocytopenia
        • Telitacicept
        • Placebo
        • Hefei, Anhui, China
        • +21 more
        Aug 18, 2023

        Chronic Primary Immune Thrombocytopenia (ITP) Trial in China (Qrelabrutinib, Placebo)

        Not yet recruiting
        • Chronic Primary Immune Thrombocytopenia (ITP)
        • Bengbu, Anhui, China
        • +13 more
        Aug 15, 2023

        Aplastic Anemia, Pure Red Cell Aplasia, Diamond Blackfan Anemia Trial run by the NHLBI (Daclizumab)

        Terminated
        Has Results
        • Aplastic Anemia
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jun 15, 2021

        Chemo-Induced Thrombocytopenia Trial (Hetrombopag)

        Not yet recruiting
        • Chemotherapy-Induced Thrombocytopenia
        • (no location specified)
        Jul 24, 2023

        Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

        Not yet recruiting
        • Immune Thrombocytopenia
        • Treatment
        • Obinutuzumab Injection [Gazyva]
        • Tianjin, China
          Chinese Academy of Medical Science and Blood Disease Hospital
        Aug 9, 2023

        Clinical Performance Evaluation of T-TAS®01 HD Chip

        Recruiting
        • Thrombocytopenia
        • T-TAS 01 HD Assay
        • San Francisco, California
        • +5 more
        Oct 11, 2023

        Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

        Not yet recruiting
        • Chemotherapy-Induced Thrombocytopenia
        • Hetrombopag Olamine
        • (no location specified)
        Jul 5, 2023

        Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

        Not yet recruiting
        • Immune Thrombocytopenia
        • Treatment
        • Obinutuzumab Injection [Gazyva]
        • Tianjin, China
          Institute of Hematology and Blood Diseases Hospital, Chinese Aca
        Oct 17, 2023